Lutronic, Inc., one of the world’s leading developers and manufacturers of medical laser systems, announced today that its MOSAIC eCO2 system, the next generation in fractional resurfacing lasers combining fractional technology with the deep ablative features of a CO2 laser, is in its late stages of FDA review and clearance.
